Our study in @JAMAPsych shows #psilocybin-assisted therapy reduced #depression symptoms in people with moderate-severe depression. 1 month later, 71% had a clinically significant response & 54% no longer met criteria for depression https://t.co/7hDkt5WIDN
We just published the 1st randomized study of #psilocybin for major depressive disorder. Over two thirds had clinically significant response & over half were in remission at follow up visits. Effect sizes met the definition of "huge" (Cohen's d=2 for stats nerds) or much larger.
Off to @ProfDavidNutt’s house about 12 years after last there where we met ahead of our v first ethics meeting for a psychedelic research study (psilocybin fmri). Today we meet to discuss our psilocybin vs escitalopram for depression trial results and finalise our report.
Thrilled to reveal our limited-edition HEAL SOUL label!
For 10+ years, we’ve supported legal & safe access to #psychedelic-assisted therapy—of which top U.S. research institutions have shown dramatic results for the treatment of PTSD, depression, end-of-life-anxiety & addiction.
.@RickDoblin, the founder of @MAPS, on how psychedelics can help individuals break free of habitual patterns of thought and see the big picture. Watch the full Long Now talk here: https://t.co/zpxwmvuua1
Scientific American article on increased use of LSD in the US in past few years…based on an analysis article in Drug & Alcohol Dependence.
https://t.co/zn8WBwWNgp
Telling that they use the word "blame" in the title rather than something like "responsible"
#Erowid#Media#LSD